These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 17449511

  • 1. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
    Balen A, Platteau P, Andersen AN, Devroey P, Helmgaard L, Arce JC, Bravelle Ovulation Induction (BOI) Study Group.
    Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
    [Abstract] [Full Text] [Related]

  • 2. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study.
    Platteau P, Andersen AN, Balen A, Devroey P, Sørensen P, Helmgaard L, Arce JC, Menopur Ovulation Induction (MOI) Study Group.
    Hum Reprod; 2006 Jul; 21(7):1798-804. PubMed ID: 16571641
    [Abstract] [Full Text] [Related]

  • 3. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
    Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M.
    Cochrane Database Syst Rev; 2019 Jan 16; 1(1):CD010290. PubMed ID: 30648738
    [Abstract] [Full Text] [Related]

  • 4. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS, Nahuis M, Bayram N, Mol BW, Van der Veen F, van Wely M.
    Cochrane Database Syst Rev; 2015 Sep 09; (9):CD010290. PubMed ID: 26350625
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
    Andersen AN, Devroey P, Arce JC.
    Hum Reprod; 2006 Dec 09; 21(12):3217-27. PubMed ID: 16873892
    [Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA.
    Hum Reprod; 2007 Mar 09; 22(3):792-7. PubMed ID: 17110396
    [Abstract] [Full Text] [Related]

  • 7. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
    Revelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M.
    Reprod Biol Endocrinol; 2006 Jul 18; 4():38. PubMed ID: 16848893
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
    Baker VL, Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE, Soules MR.
    Fertil Steril; 2009 Apr 18; 91(4):1005-11. PubMed ID: 18367182
    [Abstract] [Full Text] [Related]

  • 9. An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome.
    van Wely M, Bayram N, van der Veen F, Bossuyt PM.
    Hum Reprod; 2004 Aug 18; 19(8):1741-5. PubMed ID: 15166128
    [Abstract] [Full Text] [Related]

  • 10. Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome.
    van Wely M, Bayram N, van der Veen F, Bossuyt PM.
    Hum Reprod; 2005 Jul 18; 20(7):1827-32. PubMed ID: 15831514
    [Abstract] [Full Text] [Related]

  • 11. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec 18; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.
    J Reprod Med; 2004 Sep 18; 49(9):733-8. PubMed ID: 15493565
    [Abstract] [Full Text] [Related]

  • 13. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy.
    López E, Gunby J, Daya S, Parrilla JJ, Abad L, Balasch J.
    Reprod Biomed Online; 2004 Oct 18; 9(4):382-90. PubMed ID: 15511336
    [Abstract] [Full Text] [Related]

  • 14. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N, van Wely M, van Der Veen F.
    Cochrane Database Syst Rev; 2001 Oct 18; (2):CD002121. PubMed ID: 11406034
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J, Andersen AN, Devroey P, Arce JC, MERIT Group.
    Hum Reprod; 2007 Mar 18; 22(3):676-87. PubMed ID: 17110397
    [Abstract] [Full Text] [Related]

  • 18. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH, Platteau P, Andersen AN, Devroey P, Sørensen P, Helmgaard L, Arce JC.
    BJOG; 2006 Oct 18; 113(10):1195-202. PubMed ID: 16903840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul 18; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.